Cargando…
Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA-374a/forkhead box O1 signaling axis
Ovarian cancer is a prominent disease that demonstrates high incidence rates in women and often presents multidrug resistance. Propofol has been demonstrated to suppress the malignancy of various types of human cancer; however, the underlying molecular mechanisms of propofol in ovarian cancer remain...
Autores principales: | Sun, Yang, Peng, Yong-Bao, Ye, Ling-Ling, Ma, Long-Xian, Zou, Mei-Yan, Cheng, Zhong-Gui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003056/ https://www.ncbi.nlm.nih.gov/pubmed/32016462 http://dx.doi.org/10.3892/mmr.2020.10943 |
Ejemplares similares
-
MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3
por: Gao, Yuewen, et al.
Publicado: (2018) -
MicroRNA-544 promotes colorectal cancer progression by targeting forkhead box O1
por: Yao, Guo-Dong, et al.
Publicado: (2018) -
Forkhead box C1 is targeted by microRNA-133b and promotes cell proliferation and migration in osteosarcoma
por: Deng, Lu, et al.
Publicado: (2017) -
MicroRNA-212 suppresses the proliferation and migration of osteosarcoma cells by targeting forkhead box protein A1
por: Liu, Jian, et al.
Publicado: (2021) -
Evidence for the role of microRNA 374b in acquired cisplatin resistance in pancreatic cancer cells
por: Schreiber, R, et al.
Publicado: (2016)